197 related articles for article (PubMed ID: 25051432)
41. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors.
Onuma E; Azuma Y; Saito H; Tsunenari T; Watanabe T; Hirabayashi M; Sato K; Yamada-Okabe H; Ogata E
Clin Cancer Res; 2005 Jun; 11(11):4198-203. PubMed ID: 15930357
[TBL] [Abstract][Full Text] [Related]
42. S100A4 expression with reduced E-cadherin expression predicts distant metastasis of human malignant melanoma cell lines in the NOD/SCID/gammaCnull (NOG) mouse model.
Ikoma N; Yamazaki H; Abe Y; Oida Y; Ohnishi Y; Suemizu H; Matsumoto H; Matsuyama T; Ohta Y; Ozawa A; Ueyama Y; Nakamura M
Oncol Rep; 2005 Sep; 14(3):633-7. PubMed ID: 16077966
[TBL] [Abstract][Full Text] [Related]
43. PTHrP drives breast tumor initiation, progression, and metastasis in mice and is a potential therapy target.
Li J; Karaplis AC; Huang DC; Siegel PM; Camirand A; Yang XF; Muller WJ; Kremer R
J Clin Invest; 2011 Dec; 121(12):4655-69. PubMed ID: 22056386
[TBL] [Abstract][Full Text] [Related]
44. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
[TBL] [Abstract][Full Text] [Related]
45. Stable overexpression of Smad7 in human melanoma cells inhibits their tumorigenicity in vitro and in vivo.
Javelaud D; Delmas V; Möller M; Sextius P; André J; Menashi S; Larue L; Mauviel A
Oncogene; 2005 Nov; 24(51):7624-9. PubMed ID: 16007121
[TBL] [Abstract][Full Text] [Related]
46. Total saponins from Rubus parvifolius L. inhibits cell proliferation, migration and invasion of malignant melanoma in vitro and in vivo.
Cao J; Zhao X; Ma Y; Yang J; Li F
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33111956
[TBL] [Abstract][Full Text] [Related]
47. Analysis of the tumor vasculature and metastatic behavior of xenografts of human melanoma cell lines transfected with vascular permeability factor.
Pötgens AJ; van Altena MC; Lubsen NH; Ruiter DJ; de Waal RM
Am J Pathol; 1996 Apr; 148(4):1203-17. PubMed ID: 8644861
[TBL] [Abstract][Full Text] [Related]
48. Enhanced in-vitro and in-vivo suppression of A375 melanoma by combined IL-24/OSM adenoviral-mediated gene therapy.
Xu Y; Zhang F; Qin L; Miao J; Sheng W; Xie Y; Xu X; Yang J; Qian H
Melanoma Res; 2014 Feb; 24(1):20-31. PubMed ID: 24300090
[TBL] [Abstract][Full Text] [Related]
49. Individualized strategies to target specific mechanisms of disease in malignant melanoma patients displaying unique mutational signatures.
Curiel-Olmo S; García-Castaño A; Vidal R; Pisonero H; Varela I; León-Castillo A; Trillo E; González-Vela C; García-Diaz N; Almaraz C; Moreno T; Cereceda L; Madureira R; Martinez N; Ortiz-Romero P; Valdizán E; Piris MA; Vaqué JP
Oncotarget; 2015 Sep; 6(28):25452-65. PubMed ID: 26327537
[TBL] [Abstract][Full Text] [Related]
50. Recombinant human arginase inhibits the in vitro and in vivo proliferation of human melanoma by inducing cell cycle arrest and apoptosis.
Lam TL; Wong GK; Chow HY; Chong HC; Chow TL; Kwok SY; Cheng PN; Wheatley DN; Lo WH; Leung YC
Pigment Cell Melanoma Res; 2011 Apr; 24(2):366-76. PubMed ID: 21029397
[TBL] [Abstract][Full Text] [Related]
51. Expression of interleukin 8 and not parathyroid hormone-related protein by human breast cancer cells correlates with bone metastasis in vivo.
Bendre MS; Gaddy-Kurten D; Mon-Foote T; Akel NS; Skinner RA; Nicholas RW; Suva LJ
Cancer Res; 2002 Oct; 62(19):5571-9. PubMed ID: 12359770
[TBL] [Abstract][Full Text] [Related]
52. Anti-tumor effect in human breast cancer by TAE226, a dual inhibitor for FAK and IGF-IR in vitro and in vivo.
Kurio N; Shimo T; Fukazawa T; Takaoka M; Okui T; Hassan NM; Honami T; Hatakeyama S; Ikeda M; Naomoto Y; Sasaki A
Exp Cell Res; 2011 May; 317(8):1134-46. PubMed ID: 21338601
[TBL] [Abstract][Full Text] [Related]
53. Parathyroid hormone-related protein as a growth regulator of prostate carcinoma.
Dougherty KM; Blomme EA; Koh AJ; Henderson JE; Pienta KJ; Rosol TJ; McCauley LK
Cancer Res; 1999 Dec; 59(23):6015-22. PubMed ID: 10606251
[TBL] [Abstract][Full Text] [Related]
54. Impact of carboplatin plus paclitaxel combined with endostar against A375 melanoma cells: An in vitro and in vivo analysis.
Zheng AW; Jia DD; Xia LM; Jin G; Wu H; Li T
Biomed Pharmacother; 2016 Oct; 83():1321-1326. PubMed ID: 27571875
[TBL] [Abstract][Full Text] [Related]
55. Effect of curcumin on the proliferation, apoptosis, migration, and invasion of human melanoma A375 cells.
Zhang YP; Li YQ; Lv YT; Wang JM
Genet Mol Res; 2015 Feb; 14(1):1056-67. PubMed ID: 25730045
[TBL] [Abstract][Full Text] [Related]
56. Deficiency of the parathyroid hormone-related peptide nuclear localization and carboxyl terminal sequences leads to premature skin ageing partially mediated by the upregulation of p27.
Jiang M; Chen G; Lu N; Zhang Y; Jin S; Karaplis A; Goltzman D; Miao D
Exp Dermatol; 2015 Nov; 24(11):847-52. PubMed ID: 26121068
[TBL] [Abstract][Full Text] [Related]
57. Matricellular TSP-1 as a target of interest for impeding melanoma spreading: towards a therapeutic use for TAX2 peptide.
Jeanne A; Boulagnon-Rombi C; Devy J; Théret L; Fichel C; Bouland N; Diebold MD; Martiny L; Schneider C; Dedieu S
Clin Exp Metastasis; 2016 Oct; 33(7):637-49. PubMed ID: 27349907
[TBL] [Abstract][Full Text] [Related]
58. TRAF6 regulates melanoma invasion and metastasis through ubiquitination of Basigin.
Luo Z; Zhang X; Zeng W; Su J; Yang K; Lu L; Lim CB; Tang W; Wu L; Zhao S; Jia X; Peng C; Chen X
Oncotarget; 2016 Feb; 7(6):7179-92. PubMed ID: 26769849
[TBL] [Abstract][Full Text] [Related]
59. Knockdown of EIF3D suppresses proliferation of human melanoma cells through G2/M phase arrest.
Li H; Zhou F; Wang H; Lin D; Chen G; Zuo X; Sun L; Zhang X; Yang S
Biotechnol Appl Biochem; 2015; 62(5):615-20. PubMed ID: 25322666
[TBL] [Abstract][Full Text] [Related]
60. CD10-Equipped Melanoma Cells Acquire Highly Potent Tumorigenic Activity: A Plausible Explanation of Their Significance for a Poor Prognosis.
Oba J; Nakahara T; Hashimoto-Hachiya A; Liu M; Abe T; Hagihara A; Yokomizo T; Furue M
PLoS One; 2016; 11(2):e0149285. PubMed ID: 26881775
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
